Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Secco, K; Baumann, PM; Pöttler, T; Aberer, F; Cigler, M; Elsayed, H; Harer, CM; Weitgasser, R; Schütz-Fuhrmann, I; Mader, JK.
Glycemic Control Assessed by Intermittently Scanned Glucose Monitoring in Type 1 Diabetes during the COVID-19 Pandemic in Austria.
Sensors (Basel). 2024; 24(14):
Doi: 10.3390/s24144514
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Mader Julia
- Secco Katharina
- Co-Autor*innen der Med Uni Graz
- Aberer Felix
- Baumann Petra Martina
- Cigler Monika
- Elsayed Hesham
- Harer Clemens Martin
- Pöttler Tina
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- OBJECTIVE: The aim of this analysis was to assess glycemic control before and during the coronavirus disease (COVID-19) pandemic. METHODS: Data from 64 (main analysis) and 80 (sensitivity analysis) people with type 1 diabetes (T1D) using intermittently scanned continuous glucose monitoring (isCGM) were investigated retrospectively. The baseline characteristics were collected from electronic medical records. The data were examined over three periods of three months each: from 16th of March 2019 until 16th of June 2019 (pre-pandemic), from 1st of December 2019 until 29th of February 2020 (pre-lockdown) and from 16th of March 2020 until 16th of June 2020 (lockdown 2020), representing the very beginning of the COVID-19 pandemic and the first Austrian-wide lockdown. RESULTS: For the main analysis, 64 individuals with T1D (22 female, 42 male), who had a mean glycated hemoglobin (HbA1c) of 58.5 mmol/mol (51.0 to 69.3 mmol/mol) and a mean diabetes duration 13.5 years (5.5 to 22.0 years) were included in the analysis. The time in range (TIR[70-180mg/dL]) was the highest percentage of measures within all three studied phases, but the lockdown 2020 phase delivered the best data in all these cases. Concerning the time below range (TBR[<70mg/dL]) and the time above range (TAR[>180mg/dL]), the lockdown 2020 phase also had the best values. Regarding the sensitivity analysis, 80 individuals with T1D (26 female, 54 male), who had a mean HbA1c of 57.5 mmol/mol (51.0 to 69.3 mmol/mol) and a mean diabetes duration of 12.5 years (5.5 to 20.7 years), were included. The TIR[70-180mg/dL] was also the highest percentage of measures within all three studied phases, with the lockdown 2020 phase also delivering the best data in all these cases. The TBR[<70mg/dL] and the TAR[>180mg/dL] underscored the data in the main analysis. CONCLUSION: Superior glycemic control, based on all parameters analyzed, was achieved during the first Austrian-wide lockdown compared to prior periods, which might be a result of reduced daily exertion or more time spent focusing on glycemic management.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- Diabetes Mellitus, Type 1 - blood, epidemiology
- COVID-19 - epidemiology, blood
- Male - administration & dosage
- Austria - epidemiology
- Female - administration & dosage
- Blood Glucose Self-Monitoring - methods
- Adult - administration & dosage
- Blood Glucose - analysis
- Glycemic Control - methods
- Glycated Hemoglobin - analysis
- Retrospective Studies - administration & dosage
- Middle Aged - administration & dosage
- Pandemics - administration & dosage
- SARS-CoV-2 - isolation & purification
- Young Adult - administration & dosage
- Adolescent - administration & dosage
- Find related publications in this database (Keywords)
- COVID-19
- glycemic control
- isCGM
- lockdown
- pandemic
- type 1 diabetes